MISSION

To bring scientists, executives and other biopharmaceutical professionals from the Pacific Rim countries together to discuss the latest advances in the biotechnology/pharmaceutical world, the unprecedented challenges and promises facing the industry, and the breathtaking developments and opportunities in Asia/Pacific countries.

 
BioPacific Conference 2016 (aka 18th Annual Conference of CABS, Chinese- American BioPharmaceutical Society), will be held on May 7th, 2016 in the San Francisco Bay Area at San Mateo Marriott, 1770 South Amphlett Blvd., San Mateo, CA. This full-day event is expected to attract over 400 attendees of life science professionals from the great San Francisco Bay Area.

Date and Time:May 7th, Saturday, 2016, 8:00AM-9:00PM

Location: San Mateo Marriott, 1770 South Amphlett Blvd., San Mateo, CA 94402
The theme of the BioPacific Conference 2016 will be “Shooting for the Stars – Entering the Dawn of Unprecedented Breakthroughs in Life Sciences & Medicine”.

Our meeting will showcase:
Confirmed Speakers
Gerald Chan Dr. Gerald Chan
Co-founder
Morningside Group
Jennifer Hu Dr. Jennifer Hu
Venture Partner
Qiming Venture Partners US
Connie Sun Dr. Connie Sun
Senior Vice President of Business & Corporate Development
Pharmaron
Hui Zhang Mr. Hui Zhang (张辉)
Deputy Director, Investment and Partnership Branch (投资合作局副局长)
Ningbo Hangzhou Bay New Zone (宁波杭州湾新区)
Robert Lou Mr. Robert Lou (楼国强)
Manager Director (总经理)
Ningbo Kangtaibo Technology Development Co.,Ltd(宁波康泰博科技发展有限公司)
Darren Ji Dr. Darren Ji
Vice President and Global Head
Roche Partnering Asia and Emerging Markets
Hari Kumar Dr. Hari Kumar
Ex CEO and BOD
Adheron Therapeutics Inc.
Piers Whitehead Mr. Piers Whitehead
Executive Vice President & Chief Business Officer
PaxVax
Mark Selby Dr. Mark Selby
Senior Director of Immuno-Oncology
Bristol-Myers Squibb
Stanley Lei Qi Dr. Stanley Lei Qi
Assistant Professor in the Department of Bioengineering, and of Chemical and Systems Biology and faculty fellow in the interdisciplinary Institute for Chemistry, Engineering, and Medicine for Human Health (ChEM-H)
Stanford University
Tom L. Irving Mr. Tom L. Irving
Partner
Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Shawn Qian Ph.D. Dr. Shawn Qian
Co-Founder, President & CEO
NeuPharma
Wen Li Dr. Wen Li
Associate
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Xian-Ping Lu Dr. Xian-Ping Lu
Chief Executive Officer & Chief Scientific Officer
Chipscreen Biosciences Ltd
Dan Zhang Dr. Dan Zhang
Chairman and CEO
Fountain Medical Development Ltd
Alexis Ji Dr. Alexis Ji
Ph.D., MBA, Principal
WuXi Healthcare Ventures
James Zhao Dr. James Zhao
Founding Partner
LYFE Capital
Yuwen Liu Ms. Yuwen Liu
Founding Partner
Bohe Angel Fund
 Min Cui Dr. Min Cui
Founding Partner and Managing Director
Decheng Capital
Vincent Liu Dr. Vincent Liu
Senior Consultant
Wanbang Biopharmaceutical Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
 Shawn Lee Dr. Shawn Lee
Vice-Chairman
Xinbang Pharmaceutical
Cheng Liu Dr. Cheng Liu
Founder and CEO
Eureka Therapeutics
 Jinqun Yin Mr. Jinqun Yin
MBA, Vice President
Chengdu Kanghong Pharmaceutical Group Co., Ltd
Xiaodong Yang Dr. Xiaodong Yang
President and Chief Executive Officer
Apexigen
 Charles Comey Mr. Charles Comey
Partner
Morrison & Foerster
Cheni Kwok Dr. Cheni Kwok
Senior Consultant
Shanghai Medicilon